Targeting BCMA in Multiple Myeloma Carlyn Rose TanUrvi A. Shah Multiple Myeloma (P Kapoor, Section Editor) 25 August 2021 Pages: 367 - 383
Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma: Same Disease Spectrum but Two Distinct Diagnoses Kathryn A. F. KlineMichael E. KallenJennie Y. Law Acute Lymphocytic Leukemias (M Keng and F El Chaer, Section Editors) 21 August 2021 Pages: 384 - 393
Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia Ahmed AleemAli R. HaqueElizabeth A. Griffiths Acute Lymphocytic Leukemias (M Keng and F El Chaer, Section Editors) 06 October 2021 Pages: 394 - 404
Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia Danielle HammondGuillermo Montalban-Bravo Myelodysplastic Syndromes and MPN/MDS Overlap (M Patnaik, Section Editor) 09 September 2021 Pages: 405 - 417
Elevating Twitter-Based Journal Club Discussions by Leveraging a Voice-Based Platform: #HemepathJC Meets Clubhouse Aadil AhmedKamran M. MirzaSanam Loghavi Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor) 29 September 2021 Pages: 418 - 421
BTK Inhibitors in Chronic Lymphocytic Leukemia Sameh GaballaJavier Pinilla-Ibarz Chronic Lymphocytic Leukemias (N Jain, Section Editor) 02 October 2021 Pages: 422 - 432
Treatment-Free Remission: the New Goal in CML Therapy Ehab AtallahKendra Sweet Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors) 07 October 2021 Pages: 433 - 439
Challenges in Chronic Myeloid Leukemia Management in South America Katia B. PagnanoAna Ines VarelaVirginia Abello Polo Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors) 15 October 2021 Pages: 440 - 447
The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML) Heather R. WolfeLindsay A. M. Rein Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors) 18 October 2021 Pages: 448 - 454
Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic Tiziano BarbuiValerio De Stefano Myeloproliferative Neoplasms (BL Stein, Section Editor) 29 September 2021 Pages: 455 - 463
Avapritinib in the Treatment of Systemic Mastocytosis: an Update Samantha BelowLaura C. Michaelis Myeloproliferative Neoplasms (BL Stein, Section Editor) 27 September 2021 Pages: 464 - 472
Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera Joan HowGabriela Hobbs Myeloproliferative Neoplasms (BL Stein, Section Editor) 03 September 2021 Pages: 473 - 482
Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials Brady L. Stein Myeloproliferative Neoplasms (BL Stein, Section Editor) 09 September 2021 Pages: 483 - 489
